Zhejiang Medicine (600216.SH) has announced a forecasted increase, expecting a net profit of 1.039-1.246 billion yuan in 2024, an increase of 141.83%-190.01% compared to the previous year.

Zhejiang Medicine (600216.SH) issued an announcement, stating that the company is expected to achieve a net profit attributable to the owners of the parent company of 1.039 billion to 1.246 billion yuan in 2024. Compared with the same period last year, it will increase by 609.36 million to 816.36 million yuan, a year-on-year increase of 141.83% to 190.01%.